Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC

NCT00356941 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Withdrawn due to lack of accrual

Conditions

Lung Cancer

Interventions

DRUG: docetaxel
DRUG: oxaliplatin
PROCEDURE: radiation therapy

Sponsor

Masonic Cancer Center, University of Minnesota